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BACKGROUND AND PURPOSE: Gait is a complex process involving various cortical and subcortical brain regions. An acute stroke 
or transient ischemic attack (TIA) may disrupt white and gray matter integrity and, therefore, affect gait in patients without 
evident neurological signs. We determined whether patients with stroke and TIA experience subtle changes in global gait 
and several independent gait domains.
METHODS: In the population-based Rotterdam Study, 4456 participants (median age, 65 years; 55% women) underwent 
detailed quantitative gait assessment (GAITRite) between 2009 and 2016. We summarized 30 gait parameters into a global 
gait score and 7 mutually independent gait domains. First, we assessed the association between prior stroke or TIA and 
global and domain-specific gait using linear regression models adjusted for age, sex, vascular risk factors, and cognition. 
Subsequently, we repeated the analysis stratified by the presence of different neurological symptoms in a subgroup of 
participants with ischemic stroke after study entry.
RESULTS: Compared with participants without prior stroke, patients with stroke had a worse global gait (SD, −0.49 [95% CI, 
−0.64 to −0.34]), especially in the gait domains Pace, Phases, and Turning. The detrimental effect of stroke on gait was 
amplified in participants with worse cognition. No gait differences were found between participants with and without prior 
TIA. Ischemic stroke patients without lower limb weakness, loss of coordination, or visuospatial problems still had a worse gait 
compared with participants without stroke. Stratification by different stroke symptoms showed that different gait domains 
were affected in each group.
CONCLUSIONS: Prior stroke without neurological signs that affect gait is still associated with gait difficulties compared 
with individuals without stroke. Our study suggests that stroke not only has a direct impact on gait through neurological 
impairments but also includes an indirect effect possibly through disruption of gray and white matter integrity and accelerated 
neurodegeneration.
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Patients with stroke often experience difficulties with gait, which subsequently can lead to func-tional dependency, falls, and mortality.1,2 Gait is 
a complex process involving an interplay of various 
cortical brain regions, white matter tracts, and the 
peripheral nervous system.3 Apart from poststroke 
gait difficulties due to lower limb weakness, loss of 
coordination, or visuospatial problems, subtle changes 
in the brain including small vessel disease are also 
linked to walking problems, most likely through dis-
ruption of the intra- and interhemispheric integration 
of motor and sensory signals.4–6 Moreover, because 
gait is also dependent on several cognitive abilities 
such as executive function and attention,7 poststroke 
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cognitive impairment may further negatively impact 
gait in these patients.8
In view of these observations, we hypothesized that 
patients experiencing a stroke or transient ischemic 
attack (TIA), without neurological signs that affect gait, 
may also experience subtle changes in their gait pat-
terns, in particular, those who are cognitively impaired. 
Thus far, only 1 study has investigated gait in 12 patients 
with minor stroke and TIA and found worse gait speed, 
step length, and double support.9 This small study high-
lighted that problems with gait may be subtle and not 
easily assessable with standard neurological examina-
tion. Conversely, quantitative assessment can reveal 
different aspects of a person’s gait pattern, including 
various domains such as Base of Support (stride width), 
Rhythm (stride time), and Tandem (heel-to-toe walking).
In the current study, we determined whether patients 
with a stroke or TIA experience subtle changes in global 
and domain-specific gait and whether cognition modi-
fies this association. Specifically, we examined whether 
stroke patients without lower limb weakness, loss of 
coordination, or visual problems still experienced subtle 
gait problems compared with participants without stroke.
METHODS
The Rotterdam Study data can be made available to interested 
researchers upon request. Requests can be directed to data 
manager Frank J.A. van Rooij (f.vanrooij@erasmusmc.nl). We 
are unable to place data in a public repository due to legal and 
ethical restraints. Sharing of individual participant data was 
not included in the informed consent of the study, and there 
is potential risk of revealing participants’ identities as it is not 
possible to completely anonymize the data. This is of particular 
concern given the sensitive personal nature of much of the data 
collected as part of the Rotterdam Study.
Study Population
This study was embedded in the Rotterdam Study—a prospec-
tive population-based cohort based in the Netherlands inves-
tigating causes and consequences of diseases in people aged 
≥45 years.10 The study was initiated in 1990 and expanded in 
2000 and 2005 and currently consists of 14 926 participants. 
At study entry and every 4 years, participants are interviewed 
at home and undergo extensive physical examination at the 
research center. Gait assessment has been implemented in 
the core protocol since March 2009. In total, 6405 partici-
pants were asked to participate of whom eventually 4525 
underwent gait assessment between 2009 and 2016 (Table I 
in the Data Supplement). We used the first gait assessment of 
each participant. Participants who did not give informed con-
sent to review their medical records (n=22) or who were lost 
to continuous follow-up before their gait assessment (n=47) 
were excluded, resulting in 4456 participants available for fur-
ther analysis.
The Rotterdam Study has been approved by the Medical 
Ethics Committee of the Erasmus Medical Center and by the 
Review Board of the Ministry of Health, Welfare, and Sports 
of the Netherlands according to the Population Study Act 
Rotterdam Study. All participants provided written informed 
consent to participate in the study.
Stroke and TIA Ascertainment
Stroke was defined according to the World Health Organization 
criteria as a syndrome of rapidly developing clinical signs of 
focal (or global) disturbance of cerebral function, with symp-
toms lasting ≥24 hours or leading to death, with no apparent 
cause other than of vascular origin.11 TIA was defined as an 
attack of sudden focal neurological symptom(s) that com-
pletely resolved within 24 hours, with no clear evidence for the 
diagnosis of migraine, epilepsy, Ménière disease, hyperventi-
lation, cardiac syncope, hypoglycemia, or orthostatic hypoten-
sion.12 History of stroke or TIA at study entry was assessed 
during baseline interview and verified by medical records. After 
enrollment, participants were continuously monitored for stroke 
and TIA through automated linkage of the study database with 
files from general practitioners. Nursing home physician and 
general practitioner files of participants who moved out of the 
district were checked on a regular basis as well. Additional 
information was obtained from hospital records. In the Dutch 
healthcare system, the general practitioner and nursing home 
physician function as gatekeepers for referral to second-
ary and tertiary care providers. These providers then report 
back to the general practitioner or nursing home physician, 
including when patients visit without a referral. Therefore, the 
Rotterdam Study has data on all centers participants visited, 
without limiting it to specific centers. Potential strokes were 
reviewed by research physicians and verified by an experienced 
stroke neurologist. Final stroke diagnosis was adjudicated in 
accordance with the abovementioned standardized diagnostic 
World Health Organization criteria, which were held constant 
over the entire follow-up time. Stroke subtype (hemorrhagic or 
ischemic), location, cause, and other stroke-specific charac-
teristics were based on neuroimaging reports or hospital dis-
charge letters. If these were absent, then the stroke subtype 
was classified as unspecified. Follow-up until January 2016 
was virtually complete (person-years/potential person-years, 
96.5%). Participants were identified as prior stroke or TIA when 
they had a history of stroke or TIA before their gait assessment. 
For participants who had a history of stroke at study entry in 
the Rotterdam Study, complete information on the neurologi-
cal signs during the event was not always available. Therefore, 
for the analysis stratified by neurological symptoms, we only 
included participants who had an ischemic stroke during follow-
up in the Rotterdam Study but before gait assessment (n=76). 
For these participants, medical records including neurological 
signs during the event were available, and all neurological signs 
and localization mentioned by the physician were noted. For 
participants who had multiple strokes before gait assessment 
(n=8), we gathered all neurological signs of every event. The 
Nonstandard Abbreviations and Acronyms
HDL high-density lipoprotein
TIA transient ischemic attack
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medical records of 1 participant were not completely available, 
and this participant was excluded.
Gait Assessment
Gait was evaluated using a 5.79-m-long walkway (GAITRite 
Platinum; CIR Systems, Sparta, NJ; 4.88-m active area; 120-Hz 
sampling rate)—a reliable and valid device for the evaluation of 
gait.13,14 The standardized gait protocol consisted of 3 walking 
conditions: normal walk, tandem walk, and turning walk. In the 
normal walk, participants walked across the walkway at their 
usual pace. This walk was performed 8×; the first recording 
was considered a practice walk. In the tandem walk, participants 
walked heel-to-toe on a line across the walkway. In turning walk, 
participants walked the walkway at their usual pace, turned half-
way, and returned to the starting position. The tandem and turning 
walk were performed once. After visual inspection of the record-
ings, the walkway software calculated 30 parameters based on 
the recorded gait, including 25 parameters for the normal walk, 
3 parameters for the tandem walk, and 2 parameters for the 
turning walk (Table II in the Data Supplement).15 We performed 
a principal component analysis with Varimax rotation to sum-
marize gait parameters into independent domains as previously 
described in detail.15 This approach yielded 7 independent gait 
domains with an eigenvalue above 1, which we labeled in accor-
dance with the gait parameters that were highly correlated with 
that domain: Base of Support, Pace, Phases, Rhythm, Tandem, 
Turning, and Variability (Figure 1).15 Global gait—a reflection of 
the gait pattern in general—was calculated by averaging the 7 
gait domains and standardizing them into a Z score.
Covariates
Educational attainment, smoking status, and physical activ-
ity were assessed during the home interview. To quantify 
the intensity of activity, we assigned metabolic equivalent of 
task scores to all activities according to the Compendium of 
Physical Activities.16 Metabolic equivalent of task hours per 
week was calculated by multiplying the metabolic equivalent 
of task scores with hours per week spent in each activity. Body 
mass index was calculated as weight (kg) divided by the square 
of height (m2). Blood pressure was measured at the right upper 
arm using a sphygmomanometer during 2 consecutive read-
ings, and the average of the 2 readings was used for further 
analysis. Blood samples were drawn to assess lipid and glucose 
levels. Diabetes mellitus type 2 was defined as a fasting glu-
cose of ≥7.0 mmol/L, a nonfasting or post-load serum glucose 
of ≥11.1 mmol/L, or blood glucose–lowering medication use. 
Furthermore, diagnosis of diabetes mellitus type 2 and atrial 
fibrillation was based on repeated screening and review of 
medical records. Participants also underwent extensive cogni-
tive assessment including verbal fluency test, 15-word learn-
ing test, letter-digit substitution test, Stroop test, and Purdue 
pegboard test.17 We calculated global cognition (g factor) as 
the first component of a principal component analysis that 
incorporated tasks from all available cognitive function tests. 
For tests with multiple subtasks, only one subtask was included 
to prevent highly correlated tasks distorting the factor loadings 
(ie, the interference task for Stroop test and delayed recall task 
for 15-word learning test). The g factor explained 53.5% of the 
variance in cognitive test scores in our study population.
Statistical Analysis
All individuals who participated in gait assessment had com-
plete data on the normal walk; data on tandem walk were miss-
ing in 6% of the participants and data on turning walk in 4% of 
the participants. The percentage of missing values in covariates 
ranged from 0.4% to 3.4%. We used multiple imputation for 
missing data on gait parameters and covariates based on all 
covariates and outcome. Gait parameters with a skewed distri-
bution were log transformed.
We determined the association between prior stroke or 
TIA and global gait and gait domains using linear regression 
models. Model I was adjusted for age and sex; model II com-
promised additional adjustments for education, smoking, body 
mass index, cholesterol, HDL (high-density lipoprotein), systolic 
and diastolic blood pressure, blood pressure–lowering medica-
tion, lipid-lowering medication, diabetes mellitus type 2, atrial 
fibrillation, and smoking; and in model III, an additional adjust-
ment for global cognition (g factor) was added. We tested for 
Figure 1. Independent gait domains.
We performed a principal component 
analysis to summarize gait parameters into 
7 independent domains: Base of support, 
pace, phases, rhythm, tandem, turning, and 
variability. For each gait domain, a single 
gait parameter that has high correlation 
with the domain is illustrated.
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effect modification of cognition between the association of 
prior stroke/TIA and global gait by adding an interaction term 
between global cognition and stroke/TIA to model III and by 
repeating the analysis for stroke after stratification by mean 
global cognition.
Furthermore, we repeated the analysis and determined 
the association between prior stroke and gait after stratifi-
cation by the presence of neurological signs that may affect 
gait (weakness, sensory symptoms, disturbed coordination or 
reduced skillfulness in the lower limbs, reported walking dif-
ficulty, neglect, visual deficit, or diplopia), presence of isolated 
aphasia (as a reliable symptom indicating cortical involvement), 
and clinical localization of stroke.
Data analysis was performed using IBM SPSS, version 25, 
and R, version 3.6.2, software.
RESULTS
In total, 4456 participants completed gait assessment 
and were included in the analysis. Mean age (SD) of 
these participants was 67.4 years (9.5), and 55.1% were 
women (Table 1). Of these participants, 147 (3.3%) 
experienced a stroke and 202 (4.5%) a TIA before their 
gait assessment.
Participants with prior stroke had a −0.49-SD (95% 
CI, −0.64 to −0.34) worse global gait compared with 
those without a history of stroke (Table 2). The associa-
tion attenuated slightly after adjusting for vascular risk 
factors and additionally for global cognition. Of the 7 
independent gait domains, participants with prior stroke 
had in particular worse scores on Pace, Phases, and Turn-
ing compared with those without stroke (Figure 2A). In 
contrast, patients with a TIA did not have worse global or 
domain-specific gait compared with those free of stroke 
and TIA. We found a significant interaction between 
stroke and global cognition (SD, −0.19 [95% CI, −0.31 
to −0.07]; P for interaction, <0.005) but not between TIA 
and global cognition. The effect of prior stroke on gait 
was even more detrimental in participants with worse 
global cognition compared with those with cognition 
scores above the mean (Figure 2B), especially on global 
gait and the Phases domain.
In total, 76 participants were stroke free at study entry 
in the Rotterdam Study but had an ischemic stroke dur-
ing study follow-up and before gait assessment. The first 
stroke event of these patients occurred with a median 
(SD) of 4.3 years (4.5) before gait assessment. Most 
frequently reported neurological signs were weakness 
of the upper limb (46.7%), weakness of the lower limb 
(38.7%), and aphasia (33.3%; Table 3). The participants 
with prior stroke had a −0.51-SD (95% CI, −0.70 to 
−0.31) worse global gait compared with stroke-free par-
ticipants in the fully adjusted model. Stratification by neu-
rological symptoms showed that stroke patients without 
lower limb paresis or visuospatial symptoms during the 
event still had a worse global gait compared with par-
ticipants without stroke (SD, −0.57 [95% CI, −0.91 to 
−0.24]; Table III in the Data Supplement). Regarding gait 
domains, patients with lower limb paresis or visuospatial 
symptoms were the most affected in the Phases domain, 
whereas stroke patients without these symptoms had in 
particular a worse Rhythm (Figure 3A). Stroke patients 
with aphasia as their only symptom still had a worse gait 
than participants without stroke (SD, −0.95 [95% CI, 
−1.51 to −0.40]; Table II Data Supplement), they were in 
particular affected in the Tandem and Turning domains. 
Finally, a stroke in the left or right hemisphere was asso-
ciated with a worse global gait, whereas stroke in the 
cerebellum/brain stem was not significantly associated 
with a worse gait (Table III Data Supplement; Figure 3C). 
Left hemispheric stroke was most strongly associated 
with a worse Tandem, and right hemispheric stroke was 
in particular associated with impairments in the Phases 
domain.
DISCUSSION
In this study, we found that prior stroke without lower limb 
weakness, loss of coordination or visuospatial problems 
Table 1. Baseline Characteristics of Study Population 
(n=4456)
Characteristic  
Age at gait assessment, y 67.4 (9.5)
Women 2453 (55.1)
Educational attainment
 Primary 359 (8.1)
 Low/intermediate 1687 (37.9)
 Intermediate 1372 (30.8)
 Higher 1038 (23.3)
Systolic blood pressure, mm Hg 141 (21)
Diastolic blood pressure, mm Hg 83 (11)
Blood pressure–lowering medication use 1903 (42.7)
Body mass index, kg/m2 27.3 (4.2)
Total serum cholesterol, mmol/L 5.5 (1.1)
Serum high-density lipoprotein, mmol/L 1.5 (0.4)
Lipid-lowering medication use 1326 (29.8)
Smoking status
 Current 581 (13.0)
 Former 2406 (54.0)
 Never 1469 (33.0)
Prior stroke 147 (3.3)
Prior transient ischemic attack 276 (6.2)
Diabetes mellitus type 2 648 (14.5)
Atrial fibrillation 236 (5.3)
Physical activity, MET-hours per week*; median 
(interquartile range)
42.0 (17.7–79.7)
Data presented as frequency (percentage) for categorical values and 
mean±SD for continuous variables, unless stated otherwise. MET indicates 
metabolic equivalent of task.
*Data on physical activity were missing in n=716 participants.
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at the time of the event was associated with a worse gait 
compared with stroke-free participants, especially in par-
ticipants with cognitive impairment. Furthermore, impair-
ments in different gait domains were associated with 
stroke patients with different neurological symptoms. 
These results suggest that a stroke not only affects gait 
in patients in a direct way due to obvious physical impair-
ment but has an additional detrimental impact on gait 
through other pathways.
One previous study also reported several gait parame-
ters in 12 minor stroke and TIA patients.9 These patients 
had a worse gait speed, step length, and double support 
compared with healthy controls. These gait parameters 
could be compared with the Pace and Phases domains 
of our study. However, this study included 4 patients 
(25%) who did report gait disturbances at the time of 
the event, and no adjustments for vascular risk factors or 
cognition were made. Moreover, an additional difference 
with the study was that gait was assessed on average 
20 weeks after the event, whereas our study assessed 
gait in participants with various time after stroke and TIA. 
Although this can highlight the more long-term conse-
quences of stroke and TIA, it does provide a more het-
erogeneous group.
We found that prior stroke without gait-affecting neu-
rological signs was associated with a worse global gait 
compared with participants without a history of stroke. 
However, different gait domains were impaired in different 
Table 2. Association of Global Gait and Different Gait Categories With Prior Stroke
Global Gait (SD)
Model I Model II Model III
Prior stroke
 No. of participants with stroke/no stroke 147/4301
 β (95% CI) −0.49 (−0.64 to −0.34)* −0.44 (−0.58 to −0.29)* −0.34 (−0.48 to −0.19)*
Prior TIA
 No. of participants with TIA/no TIA or stroke 202/4107
 β (95% CI) −0.07 (−0.20 to 0.05) −0.06 (−0.18 to 0.06) −0.03 (−0.15 to 0.09)
Model I: adjusted for age and sex. Model II: additional adjustments for education, smoking, BMI, cholesterol, HDL, systolic and diastolic blood pressure, blood pressure–
lowering medication, lipid-lowering medication, diabetes mellitus type 2, atrial fibrillation, and smoking. Model III: additional adjustment for global cognition. BMI indicates 
body mass index; HDL, high-density lipoprotein; and TIA, transient ischemic attack.
*Significant (P<0.05) association.
Figure 2. Association of prior stroke 
and transient ischemic attack (TIA) 
with gait.
A, Association of prior stroke and TIA with 
global gait and independent gait domains. 
Data points represent SD change of 
global gait or gait domain in participants 
with prior stroke (gray marker) or prior TIA 
(gray circle) compared with participants 
without stroke or TIA; bars indicate 95% 
CIs. Analyses were adjusted for age, sex, 
education, smoking, body mass index (BMI), 
cholesterol, HDL (high-density lipoprotein), 
systolic and diastolic blood pressure, blood 
pressure–lowering medication, lipid-lowering 
medication, diabetes mellitus type 2, atrial 
fibrillation, smoking, and global cognition. 
B, Association of prior stroke with global 
gait and independent gait domains after 
stratification by mean global cognition. Data 
points represent SD change of global gait or 
gait domain in participants with prior stroke 
compared with participants without stroke; 
bars indicate 95% CIs. Analyses were 
adjusted for age, sex, education, smoking, 
BMI, cholesterol, HDL, systolic and diastolic 
blood pressure, blood pressure–lowering 
medication, lipid-lowering medication, 
diabetes mellitus type 2, atrial fibrillation, 
and smoking.
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patient groups. Lower limb paresis or visuospatial symp-
toms were most strongly associated with difficulties in the 
Base of Support, Phases, and Turning gait domain, which 
correlate with the classic hemiparetic gait characterized 
by poor disrupted equilibrium reactions and reduced 
weight bearing on the paretic limb.8,18 Prior stroke without 
these symptoms was associated with difficulties in the 
Pace, Phases, Tandem, Turning, and Rhythm gait domains. 
Furthermore, both right and left hemisphere strokes were 
associated with a poor global gait compared with stroke-
free participants. Left hemispheric strokes were in partic-
ular associated with impairments in the Tandem domain, 
whereas right hemispheric strokes were mostly associ-
ated with worse scores on the Phases domain. In con-
trast, prior strokes in the cerebellum/brain stem were not 
significantly associated with poor gait. This last finding is 
based on a small number of stroke patients (n=13), and 
replication in different studies is needed.
It is conceivable that the association of prior stroke 
without lower limb paresis or visuospatial symptoms 
with gait impairments can be explained by so called 
higher level gait disorders: walking difficulties that are 
due to disturbance of the highest sensorimotor systems 
that cannot be accounted for by obvious neurological 
signs.19 Indeed, small vessel disease including white 
matter hyperintensities and lacunar infarcts, especially 
in the frontal and periventricular regions, is associated 
with gait difficulties.4–6 In particular, loss of white mat-
ter microstructure integrity in interconnecting cortical 
and thalamic regions is linked to worse global gait and 
several gait domains including Phases, Variability, Pace, 
Base of Support, and Turning.20,21 However, adjustment 
of vascular risk factors attenuated but did not eliminate 
the association between prior stroke and gait disorders. 
This suggests that stroke had an independent impact 
on gait, possibly by interrupting the white integrity fur-
ther and acceleration of cerebral small vessel disease. 
Similarly, gray matter, through cortical infarcts, seems 
to be involved in this process since we also found that 
stroke with isolated aphasia was still associated with gait 
impairments. We did not find worse gait in participants 
with prior TIA compared with those without TIA, suggest-
ing that these events did not result in permanent cere-
brovascular damage.
Furthermore, we found that in participants with worse 
global cognition, the association of prior stroke and gait 
impairments was amplified, suggesting that cognition is an 
effect modifier in this association. Gait is indeed dependent 
on several cognitive abilities including executive function, 
attention, and judgement of external and internal cues7 
and has previously been linked to cognitive decline and 
dementia.22–24 Cognitive impairment in patients with stroke 
is associated with concurrent gait difficulties that are 
amplified during cognitive challenging dual-task assess-
ments of gait.8,25–27 Different pathways are hypothesized: 
besides the detrimental impact of small vessel disease on 
both cognition and gait,7,22,27 evidence is also emerging 
that neurodegeneration, possibly though amyloid-β depo-
sitions, has a more direct impact on gait domains such as 
cadence and increased double support time.28
Several limitations of this study need to be discussed. 
We obtained information about neurological signs during 
the stroke event from medical records, and thus it is pos-
sible that the treating physician may not have reported 
all signs of these patients. In particular, subtle neuro-
logical symptoms may have been missed. We also did 
not systematically assess stroke severity. Furthermore, 
gait difficulties in patients with lower limb difficulties or 
visuospatial symptoms are possibly underestimated due 
to nonparticipation of participants who had a severely 
disabling stroke. However, this has likely not occurred 
in stroke patients without these neurological signs, and, 
therefore, we have no indication that the gait assessment 
in these patients is not reliable. Conversely, we cannot 
rule out that we overestimated some of the associations 
due to nonparticipation of individuals with poor gait due 
to reasons other than stroke (eg, hip osteoarthritis).
CONCLUSIONS
Our study showed that prior stroke without lower limb 
difficulties, loss of coordination, or visuospatial problems 
Table 3. Neurological Signs During Stroke Events Before 
Gait Assessment of 75 Participants
Neurological Signs at Stroke Event  
Weakness, upper limb 35 (46.7%)
Weakness, lower limb 29 (38.7%)
Aphasia 25 (33.3%)
Sensory symptom, upper limb 23 (30.7%)
Weakness, face 20 (26.7%)
Dysdiadochokinesia or reduced skillfulness, upper limb 19 (25.3%)
Sensory symptom, lower limb 14 (18.7%)
Walking difficulty 14 (18.7%)
Disturbed coordination, upper limb 13 (17.3%)
Vertigo 10 (13.3%)
Dysarthria 10 (13.3%)
Visual deficit 10 (13.3%)
Sensory symptoms, face 9 (12.0%)
Disturbed coordination, lower limb 9 (12.0%)
Reduced skillfulness, lower limb 8 (10.7%)
Neglect 3 (4.0%)
Diplopia 2 (2.7%)
Dysphagia 2 (2.7%)
Nystagmus 2 (2.7%)
Memory deficit 2 (2.7%)
Apraxia 0
Data presented as frequency (percentage).
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is still associated with a worse gait compared with 
stroke-free participants. Furthermore, we found that this 
association is amplified in participants with cognitive 
impairment. Our study suggests that stroke not only has 
a direct impact on gait through neurological impairment 
but also has an indirect effect possibly through accel-
erated gray and white matter disruption and neurode-
generation. Longitudinal research including dual-task 
and side-specific gait assessment and neuroimaging is 
needed to further elucidate the underlying pathways.
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